Related Experiment Videos
Hypertension can be treated effectively without increasing the cost of care
1Yale University School of Medicine, USA.
Insights
Effective hypertension management is achievable without escalating healthcare costs. Focusing on simplified evaluations and evidence-based therapies, rather than expensive technologies, controls blood pressure and reduces overall expenses.
Area of Science:
- Cardiovascular Medicine
- Health Economics
Background:
- Rising healthcare costs in the United States are a concern, particularly in managing hypertension.
- Effective hypertension treatment has historically been achieved without costly technology or complex programs.
Purpose of the Study:
- To review reasons for increasing hypertension care costs.
- To emphasize cost-effective hypertension management strategies for both industrialized and non-industrialized nations.
Main Methods:
- Reviewing historical data on hypertension management over the past 20-30 years.
- Analyzing cost-control factors including initial evaluation, technology adoption, therapy selection, and physician visit frequency.
Main Results:
- Hypertension costs can be controlled by simplifying initial evaluations and avoiding unproven technologies.
- Selecting therapies based on long-term data, not promotional efforts, is crucial.
- Limiting physician visits to 2-4 per year is adequate for most patients after initial blood pressure control.
Conclusions:
- Cost-effective hypertension management is possible without compromising patient outcomes.
- Simplified, evidence-based approaches are recommended for hypertension treatment programs globally.
Abstract:
There is little reason to believe that patients with hypertension cannot be treated effectively without increasing the cost of care. Yet costs in the United States continue to increase. It is of interest to review some of the reasons for this and to emphasize that the management of hypertension has been successfully carried out over the past 20-30 years without the use of expensive technology or complicated treatment programs. This is an important message to non industrialized nations that are starting hypertension treatment programs. Hypertension costs can be controlled by: (1) limiting the complexities of the initial evaluation, avoiding the temptation to employ technologies which have not been shown to improve outcome, and (2) by selecting therapy based on data that have been collected over the past 20 years, and not on the latest promotional efforts. In addition, there is evidence that limiting physician visits to 2, 3 or at the most 4 per year is adequate to control the majority of hypertensive patients after initial blood pressure control is obtained--another important factor in the cost of care ($). There is no evidence that a more expensive approach to management will improve outcome compared to a less costly approach.